Nutraceuticals Company in India
Makin Laboratories
India's Trusted Nutraceutical Third Party Manufacturing Partner
WHO-GMP Certified CDMO Delivering Innovation-Driven Manufacturing
Solutions
India's Trusted Nutraceutical Third Party Manufacturer
Your Manufacturing Partner for Scalable Nutraceutical Success
Makin Laboratories WHO-GMP certified CDMO delivering end-
to-end nutraceutical manufacturing, from R&D to commercial
launch.
• WHO-GMP Certified Facility
• 350+ Formulations Developed
• 25+ Countries Served
• 9 PCT Patents Filed
• 1,258+ Clients Served
• End-to-End CDMO Solutions
Complete Contract Manufacturing Solutions
End-to-End Nutraceutical Contract Manufacturing
Your reliable nutraceutical contract manufacturers in India.
• Product Development — Research-backed formulations
for market demand
• Custom Formulation — Unique ingredient combinations
for differentiation
• Manufacturing — Large-scale production with stringent
quality systems
• Private Label — Complete branding and packaging
solutions
• Regulatory Support — Compliance for domestic and
export markets
• Packaging — Retail-ready, innovative packaging
solutions
Manufacturing Excellence That Powers Brands
As one of the leading nutraceuticals manufacturers in India, Makin
Laboratories delivers complete manufacturing solutions from concept to
commercial launch.
Concept & Consultation — Understanding your market, target
audience, and product vision
Research & Formulation — Mechanism-based formulation design
backed by science, not guesswork
Pilot Development — Preclinical validation and safety profiling at
laboratory scale
Commercial Manufacturing — WHO-GMP certified large-scale production
with stringent QA
Packaging & Delivery — Innovative packaging and on-time delivery to
domestic & global markets
Partner With Makin Laboratories
Launch Better Products. Scale Faster. Manufacture with Confidence.
Website: https://makinlaboratories.com
Email: [email protected]
Phone: +91 8818817919
Trusted Manufacturing Partner for Nutraceutical Brands Across India & Global
Markets
Comments